Cochrane · systematic review · CD013483
Contrast‐enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
Fraquelli, M, Nadarevic, T, Colli, A, et al. · Cochrane Database of Systematic Reviews · 2022 · Cochrane Library
Hepato-BiliaryAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
2
current version
GRADE rated
2
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 1 · 50%Low 1 · 50%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Diagnostic accuracy of contrast‐enhanced ultrasound for the diagnosis of hepatocellular carcinoma
Population: adults with chronic liver disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
CEUS | no estimate extracted | 23 studies · 6546 participants | Very low Downgraded: risk of bias, inconsistency, indirectness |
Diagnostic accuracy of contrast‐enhanced ultrasound for the diagnosis of resectable hepatocellular carcinoma
Population: adults with chronic liver disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
CEUS | no estimate extracted | 13 studies · 1257 participants | Low Downgraded: risk of bias, inconsistency |